Article

NSAIDS for Acute Gout?

How do NSAIDS stack up to COX inhibitors and glucocortocoids in acute gout? This article summarizes a Cochrane review of 23 trials involving 2200 patients.

©The Len/shutterstock.com

©The Len/shutterstock.com

van Durme CG, Wechalekar MD, Landewé RM. JAMA. Clinical Evidence Synopsis: Nonsteroidal Anti-inflammatory Drugs for Treatment of Acute Gout. JAMA. June 9, 2015. 2015;313(22):2276-2277. doi:10.1001/jama.2015.1881.

 

Moderate-quality evidence showed that the pain reduction of non-steroidal anti-inflammatory drugs (NSAIDs) was similar to cyclooxygenase (COX) inhibitors and glucocorticoids for acute gout.

However, NSAIDs were associated with higher rates of adverse events than COX inhibitors.

This article summarizes a Cochrane review of 23 clinical trials involving 2,200 patients.

The European League Against Rheumatism and the American College of Rheumatology guidelines recommend colchicines, NSAIDs, COX inhibitors, or glucocorticoids.

The review suggests that COX inhibitors may be preferred over NSAIDs because of lower toxicity.

However, there are no trials directly comparing NSAIDs to colchicines and COX inhibitors to glucocorticoids.

Related Videos
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Alvin Wells, MD, PhD: Making Informed Treatment Decisions With New Testing Strategies
Alvin Wells, MD, PhD
Upcoming Research in PsA, AxSpa, with Philip Mease, MD
Philip Mease, MD, Clinical Professor, University of Washington School of Medicine and Director, Rheumatology Research, Swedish Medical Center
Signs and Symptoms of Connective Tissue Disease
Connective Tissue Disease Brings Dermatology & Rheumatology Together
© 2024 MJH Life Sciences

All rights reserved.